GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuneOnco Biopharmaceuticals (Shanghai) Inc (FRA:R9Z) » Definitions » Beginning Cash Position

ImmuneOnco Biopharmaceuticals (Shanghai) (FRA:R9Z) Beginning Cash Position : €32.38 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is ImmuneOnco Biopharmaceuticals (Shanghai) Beginning Cash Position?

ImmuneOnco Biopharmaceuticals (Shanghai)'s Beginning Cash Position for the quarter that ended in Dec. 2024 was €32.38 Mil.

ImmuneOnco Biopharmaceuticals (Shanghai)'s quarterly Beginning Cash Position declined from Dec. 2023 (€63.70 Mil) to Jun. 2024 (€39.31 Mil) and declined from Jun. 2024 (€39.31 Mil) to Dec. 2024 (€32.38 Mil).

ImmuneOnco Biopharmaceuticals (Shanghai)'s annual Beginning Cash Position declined from Dec. 2022 (€90.49 Mil) to Dec. 2023 (€81.58 Mil) and declined from Dec. 2023 (€81.58 Mil) to Dec. 2024 (€40.27 Mil).

ImmuneOnco Biopharmaceuticals (Shanghai) Beginning Cash Position Historical Data

The historical data trend for ImmuneOnco Biopharmaceuticals (Shanghai)'s Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmuneOnco Biopharmaceuticals (Shanghai) Beginning Cash Position Chart

ImmuneOnco Biopharmaceuticals (Shanghai) Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Beginning Cash Position
25.52 90.49 81.58 40.27

ImmuneOnco Biopharmaceuticals (Shanghai) Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Beginning Cash Position Get a 7-Day Free Trial 104.20 81.87 63.70 39.31 32.38

ImmuneOnco Biopharmaceuticals (Shanghai) Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

ImmuneOnco Biopharmaceuticals (Shanghai) Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of ImmuneOnco Biopharmaceuticals (Shanghai)'s Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmuneOnco Biopharmaceuticals (Shanghai) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuneOnco Biopharmaceuticals (Shanghai) Inc (FRA:R9Z) » Definitions » Beginning Cash Position
Comparable Companies
HKSE:01167 HKSE:01873 HKSE:02509 HKSE:01521 HKSE:02179 HKSE:06978 HKSE:02616 HKSE:02181 HKSE:02487 HKSE:06996 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
01541:Hong Kong
Address
1000 Zhangheng Road, Unit 15, China (Shanghai) Pilot Free Trade Zone, Pudong New Area, Shanghai, CHN
Website
http://cn.immuneonco.com
ImmuneOnco Biopharmaceuticals (Shanghai) Inc is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. It is one of the few biotechnology companies globally adopting a systematic approach to harness both the innate and adaptive immune systems. It has developed a rich pipeline of 14 drug candidates with eight ongoing clinical programs, featured by a comprehensive innate-immunity-based asset portfolio. Its pipeline reflects its extensive understanding of the frontiers of cancer biology and immunology and its expertise in turning scientific research into drug candidates.

ImmuneOnco Biopharmaceuticals (Shanghai) Headlines

No Headlines